摘要
差异化竞争战略有助于企业形成技术壁垒、增强盈余持续性,但存在前期投入大、回报周期长、收益不确定等问题,耐心资本能否促进企业使用差异化竞争战略值得研究.本文以沪深A股上市公司为样本,研究发现耐心资本能够促进企业实施差异化竞争战略,该效应在竞争激烈行业、采取非增长导向发展战略企业、处于成长期和衰退期企业中更显著.作用机制一是缓解企业融资约束,通过直接注入资金、发挥积极信号吸引其他投资者、参与公司治理降低信息不对称等方式,为企业提供长期稳定的资金支持;二是抑制管理层的短视行为,通过缓解管理层的短期业绩考核压力,为管理层提供行业前沿信息和汇聚各类研发要素,引导管理层追求差异化竞争战略;三是提升企业风险承担水平,通过设立专项风险补偿基金等方式与企业形成风险共担机制,以及参与公司治理提升企业识别、评估和管理风险的能力,推动企业选择高附加值的差异化竞争路径.经济后果检验表明,耐心资本在促进企业实施差异化竞争战略后,进一步助力企业获得市场竞争优势.本文不仅丰富了企业竞争战略领域相关研究,也为企业引入耐心资本提供了依据.
A differentiation-based competitive strategy helps firms build technological barriers and enhance earnings persistence,yet it entails substantial upfront investment,long payback periods,and uncertain returns.Whether patient capital can promote firms'adoption of differentiation-based competitive strategies thus merits investigation.Using a sample of Shanghai and Shenzhen A-share listed companies,this study finds that patient capital promotes firms'implementation of differentiation-based competitive strategies,and this effect is more pronounced among firms in highly competitive industries,firms pursuing non-growth-oriented development strategies,and firms in the growth and decline phases.The underlying mechanisms are threefold.First,patient capital alleviates firms'financing constraints by directly injecting funds,exerting a positive signaling effect to attract other investors,and participating in corporate governance to reduce information asymmetry,thereby providing firms with long-term and stable financial support.Second,it curbs managerial myopia by relieving the pressure of short-term performance evaluation on the management,providing managers with cutting-edge industry information,and consolidating various R&D resources,thereby guiding management toward the pursuit of differentiation-based competitive strategies.Third,it enhances corporate risk-taking by establishing dedicated risk compensation funds to form a risk-sharing mechanism with firms,and by participating in corporate governance to improve firms'capacity to identify,assess,and manage risks,thereby encouraging firms to choose high-value-added differentiation pathways.Economic consequence tests indicate that,after promoting firms'implementation of differentiation-based competitive strategies,patient capital further helps firms gain market competitive advantages.This study not only enriches the research on corporate competitive strategy but also provides a basis for firms to introduce patient capital.